Ensysce Biosciences (ENSC) Earnings Date, Estimates & Call Transcripts $2.38 +0.04 (+1.71%) Closing price 06/6/2025 04:00 PM EasternExtended Trading$2.43 +0.05 (+1.93%) As of 06/6/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Ensysce Biosciences Earnings Summary Ensysce Biosciences issued Q1 2025 earnings on May 13, 2025, reporting an EPS of -$1.39, which topped analysts' consensus estimates of -$3.02 by $1.63. Quarterly revenue was reported to be $1.32 million, above analyst estimates of $0.65 million. With a trailing EPS of -$6.54, Ensysce Biosciences' earnings are expected to decrease next year, from ($8.33) to ($12.77) per share. Upcoming Q2 Earnings DateAug. 13Before Market OpensEstimatedConsensus EPS (May. 13) -$3.02 Actual EPS (May. 13) -$1.39 Beat By $1.63 Actual Revenue (May. 13) $1.32MQ1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)ENSC Upcoming EarningsEnsysce Biosciences' next earnings date is estimated for Wednesday, August 13, 2025, based on past reporting schedules. Powered by Get Ensysce Biosciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Ensysce Biosciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataENSC Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ENSC Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ensysce Biosciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$4.50-$4.50-$4.50Q2 20251-$0.75-$0.75-$0.75Q3 20251-$0.72-$0.72-$0.72Q4 20251-$0.70-$0.70-$0.70 Ensysce Biosciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/13/2025(Estimated)--------5/13/2025Q1 2025-$3.02-$1.39+$1.63-$1.39$0.65M$1.32M3/10/2025Q4 2024-$2.74-$2.90 -$0.16-$2.90$0.25M$1.30M11/12/2024--$4.50$1.05+$5.55$0.07$0.25M$3.42M8/14/2024--$5.85-$3.30+$2.55-$0.22$0.30M$0.18M5/10/2024Q1 2024-$13.50-$8.25+$5.25-$0.55$0.40M$0.31M3/15/2024Q4 2023-$12.90-$16.95 -$4.05-$1.13$0.53M$0.52M11/9/2023Q3 2023-$15.90-$13.05+$2.85-$0.87$0.59M$0.44M8/11/2023Q2 2023-$40.95-$14.70+$26.25-$0.98$0.83M$0.49M Ensysce Biosciences Earnings - Frequently Asked Questions When is Ensysce Biosciences's earnings date? Ensysce Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based off last year's report dates. Learn more on ENSC's earnings history. Did Ensysce Biosciences beat their earnings estimates last quarter? In the previous quarter, Ensysce Biosciences (NASDAQ:ENSC) reported ($1.39) earnings per share (EPS) to beat the analysts' consensus estimate of ($3.02) by $1.63. Learn more on analysts' earnings estimate vs. ENSC's actual earnings. How much revenue does Ensysce Biosciences generate each year? Ensysce Biosciences (NASDAQ:ENSC) has a recorded annual revenue of $2.23 million. How much profit does Ensysce Biosciences generate each year? Ensysce Biosciences (NASDAQ:ENSC) has a recorded net income of -$10.61 million. ENSC has generated -$6.54 earnings per share over the last four quarters. What is Ensysce Biosciences's EPS forecast for next year? Ensysce Biosciences's earnings are expected to decrease from ($8.33) per share to ($12.77) per share in the next year. More Earnings Resources from MarketBeat Related Companies Ovid Therapeutics Earnings Date Natural Alternatives International Earnings Date Sol-Gel Technologies Earnings Date BioVie Earnings Date Cognition Therapeutics Earnings Date Chemomab Therapeutics Earnings Date Longeveron Earnings Date Elevation Oncology Earnings Date Mannatech Earnings Date Lipocine Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:ENSC) was last updated on 6/8/2025 by MarketBeat.com Staff From Our PartnersA better hedge than gold?While the whole world is piling into gold as a hedge… White House documents reveal Trump is betting big on ...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredElon’s “Secret Mission”Tesla, SpaceX and Starlink made billions for investors... But a meeting Elon had on March 21st, 2025, could...Behind the Markets | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredWhy hasn't Elon tweeted about this?Behind the scenes, there's an entirely different Tesla story brewing… . It's about a quiet stream of income...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ensysce Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ensysce Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ENSC Stock Free ENSC Stock Alerts